title: Concomitant giant cell arteritis and secondary adrenal insufficiency.
authors.affiliation: a Division of Rheumatology , Department of Internal Medicine , Rochester , MN , USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Krause
authors.affiliation: b Department of Anatomic and Clinical Pathology , Rochester , MN , USA.
authors.forename: A
authors.initials: A
authors.lastname: Norgan
authors.affiliation: c Division of Endocrinology , Department of Internal Medicine , Rochester , MN , USA.
authors.forename: A
authors.initials: A
authors.lastname: Vella
authors.affiliation: d Department of Internal Medicine , Mayo Clinic , Rochester , MN , USA.
authors.forename: T J
authors.initials: TJ
authors.lastname: Beckman
authors.affiliation: a Division of Rheumatology , Department of Internal Medicine , Rochester , MN , USA.
authors.forename: K J
authors.initials: KJ
authors.lastname: Warrington
mesh_terms: D000309:Adrenal Insufficiency / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D000324:Adrenocorticotropic Hormone / Q000172:deficiency*; D000368:Aged; D001706:Biopsy; D015897:Comorbidity; D004700:Endocrine System Diseases / Q000150:complications*; D005260:Female; D030342:Genetic Diseases, Inborn / Q000150:complications*; D013700:Giant Cell Arteritis / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007003:Hypoglycemia / Q000150:complications*; D011241:Prednisone / Q000627:therapeutic use; D013699:Temporal Arteries / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000324:Adrenocorticotropic Hormone; D011241:Prednisone; D006854:Hydrocortisone